"CHINESE COASTER" - 2: AT THE TURN OF 2023-2024

被引:0
|
作者
Mikheev, Vasily V. [1 ]
Lukonin, Sergei A. [1 ]
机构
[1] Russian Acad Sci, Primakov Natl Res Inst World Econ & Int Relat, IMEMO, 23 Profsoyuznaya Str, Moscow 117997, Russia
来源
关键词
China; foreign policy; domestic policy; economy;
D O I
10.20542/0131-2227-2024-68-7-68-78
中图分类号
D81 [国际关系];
学科分类号
030207 ;
摘要
The most important event in the China-U.S. relations at the end of 2023 was the meeting of Xi Jinping and J. Biden in San Francisco on the sidelines of the APEC Summit in November 2023. The meeting did not become a breakthrough in relations between the two countries, but it created the foundations for establishing cooperation in mutually beneficial areas. Agreements were reached on the restoration of military contacts, the resumption of activities of working groups on economic and financial cooperation, the development of cooperation in the fields of artificial intelligence, green economy, climate change, etc. At the same time, many economic and political issues remained unresolved: American trade and economic sanctions against China, and, most importantly, disagreements over Taiwan. Against the background of the China-U.S. Summit, Beijing policy has strengthened its two-vector nature. Before the Summit in the United States, a Sino-Russian Summit was held in Beijing in October 2023. Later, in December 2023, the China-EU Summit took place. Their results are contradictory. Xi described Sino-Russian relations as "healthy and stable". The Summit with the EU ended almost to no avail. An important foreign policy move made by Beijing was the Belt and Road Summit of October 2023, at which Chinese plans to institutionalize this strategy were announced, including the creation of the Belt and Road secretariat and "other institutions", supported with 100 bln U.S. dollars injections. In domestic politics, Xi's authoritarianism continued to strengthen, accompanied by restrictions on the freedom of speech. In the economy, China kept the GDP growth rate for 2023 in the desired range from 5 to 5.5%. The main task for Beijing in the field of economics for 2024 is at least to keep the growth rate of the national GDP at about 5%.
引用
收藏
页数:140
相关论文
共 50 条
  • [21] New Novavax Vaccine Formulation for 2023-2024
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1689): : 182 - 183
  • [22] Equine Encephalomyelitis Outbreak, Uruguay, 2023-2024
    Frabasile, Sandra
    Morel, Noelia
    Perez, Ramiro
    Marrero, Lucia Moreira
    Burgueno, Analia
    Cortinas, Maria Noel
    Bassetti, Lucia
    Negro, Raul
    Rodriguez, Sirley
    Bormida, Victoria
    Gayo, Valeria
    de Souza, Victor Costa
    Naveca, Felipe Gomes
    Gomez, Mariela Martinez
    Gresh, Lionel
    Mendez-Rico, Jairo
    Chiparelli, Hector
    Delfraro, Adriana
    EMERGING INFECTIOUS DISEASES, 2025, 31 (01) : 180 - 183
  • [23] Influenza vaccine for 2023-2024 (vol 65, pg 161, 2023)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1689): : 184 - 184
  • [24] The Year in Review: Economics at the Antitrust Division 2023-2024
    Athey, Susan
    Gross, Alex
    Marinescu, Ioana
    Shanefelter, Jennifer
    REVIEW OF INDUSTRIAL ORGANIZATION, 2024, : 809 - 829
  • [25] Analysis and Prospects of the World Economic Situation 2023-2024
    Zhang Yuyan
    Xu Xiujun
    ContemporaryWorld, 2024, (01) : 27 - 31
  • [26] Note from the Editor and Acknowledgment of Reviewers 2023-2024
    Norman, Emma R.
    POLITICS & POLICY, 2024, 52 (06) : 1198 - 1209
  • [27] Current topic of vascular function in hypertension in 2023-2024
    Maruhashi, Tatsuya
    Higashi, Yukihito
    HYPERTENSION RESEARCH, 2024, 47 (12) : 3310 - 3317
  • [28] Readings on L2 Reading: Publications in Other Venues 2023-2024
    Harris, Shenika
    Gui, Min
    Waseda, Yuya Arai
    Garton, Rachel
    READING IN A FOREIGN LANGUAGE, 2024, 36 (01): : 1 - 46
  • [29] Report of the 2023-2024 Strategic Engagement Standing Committee
    Palombi, Laura C.
    Silvia, Richard
    Dugan, Sara
    Khan, Md Omar Faruk
    Kawahara, Brian I.
    O'Neal, Katherine S.
    Robinson, Evan
    Tyler, Linda
    Unni, Elizabeth
    Shrader, Sarah
    Moore, Terri
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2024, 88 (08)
  • [30] Film review 2023-2024: Anatomy of a Palme (d'or)
    Degroult, Nathalie
    Bissiere, Michele
    Brunet, Marie-Line
    FRENCH REVIEW, 2025, 98 (03):